Vaccines Archive — Page 1 of 14

C. difficile bacteria (image courtesy of CDC/Jennifer Oosthuizen)
August 11, 2026

Vanderbilt Health evaluating vaccine for C. difficile for people 65 and older

“C. diff is one of those infections that turns a routine hospital stay or a course of antibiotics into something far more serious, and older adults bear the brunt of it.”

April 22, 2026

Child Health Poll: Vast majority of Tennessee parents say their kids get regular immunizations, support school-based immunization requirements

Roughly 8 in 10 parents surveyed across the state said they are concerned about communicable diseases like measles if others are not immunized and agreed that immunizations are important to protect their children from serious infections.

April 3, 2026

Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment

“These antibodies hold significant promise to be used in people who are at risk of measles, but who cannot respond to the measles vaccine due to their weakened immune systems,” said James Crowe Jr., MD, whose research team isolated the human monoclonal antibodies.

February 18, 2026

Novel vaccine protects against C. diff disease and recurrence

New study represents a major step forward for vaccine development for C. diff, the leading cause of health care- and antibiotic-associated infection.

February 11, 2026

Vaccination cuts risk of COVID-19 respiratory failure or death by 80%

Researchers at Vanderbilt Health and around the country continue to evaluate the effectiveness of vaccines approved by the Food and Drug Administration to reduce the severity and lethality of respiratory infections caused by the ever-mutating SARS-CoV-2 virus.

December 15, 2025

Antibody research may lead to broadly protective flu vaccine

These findings could lead to the development of cross-reactive and neutralizing antibody therapies for individuals who are severely ill from the flu.